We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,572 results
  1. An Optimized Protocol of Electroporation of Hepatocyte Nuclear Factor 1 Alpha (Hnf-1α) in Mesenchymal Stem Cells

    Abstract

    The objective of this study was to investigate the optimization of electroporation of hepatocyte nuclear factor 1 alpha ( Hnf-1 α) in murine...

    Sumreen Begum, Sehrish Jabeen, Syed Adibul Hasan Rizvi in Cytology and Genetics
    Article 04 June 2024
  2. The role of hypoxia-inducible factor 1α in hepatic lipid metabolism

    Abstract

    Chronic liver disease is a major public health problem with a high and increasing prevalence worldwide. In the progression of chronic liver...

    Mingxiao Luo, Tingting Li, Haiquan Sang in Journal of Molecular Medicine
    Article 28 March 2023
  3. The role of hypoxia-inducible factor 1 alpha (HIF-1α) modulation in heavy metal toxicity

    Hypoxia-inducible factor 1 (HIF-1) is an oxygen-sensing transcriptional regulator orchestrating a complex of adaptive cellular responses to hypoxia....

    Michael Aschner, Anatoly V. Skalny, ... Alexey A. Tinkov in Archives of Toxicology
    Article 18 March 2023
  4. Protective effect of hepatocyte-enriched lncRNA-Mir122hg by promoting hepatocyte proliferation in acute liver injury

    Some long noncoding RNAs (lncRNAs), which harbor microRNAs in their gene sequence and are also known as microRNA host gene derived lncRNAs...

    Zhenjun Yu, Yuhan Li, ... Tao Han in Experimental & Molecular Medicine
    Article Open access 24 November 2022
  5. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function

    Background

    To comprehend the influences of fenofibrate on hepatic lipid accumulation and mitochondrial function-related signaling pathways in mice...

    Xuemei Wang, Jieying Wang, ... Ke Men in BMC Pharmacology and Toxicology
    Article Open access 03 January 2024
  6. A novel mechanistic approach for the anti-fibrotic potential of rupatadine in rat liver via amendment of PAF/NF-ĸB p65/TGF-β1 and hedgehog/HIF-1α/VEGF trajectories

    Hepatic fibrosis is one of the major worldwide health concerns which requires tremendous research due to the limited outcomes of the current...

    Manar A. Didamoony, Ahmed M. Atwa, Lamiaa A. Ahmed in Inflammopharmacology
    Article Open access 22 February 2023
  7. Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells

    Non-alcoholic fatty liver disease (NAFLD) is emerging as an epidemic risk factor for hepatocellular carcinoma (HCC). The progression of NAFLD to HCC...

    Hao Shen, Han Yu, ... Yao Chen in Acta Pharmacologica Sinica
    Article 04 May 2022
  8. Hepatocyte organoids and cell transplantation: What the future holds

    Historically, primary hepatocytes have been difficult to expand or maintain in vitro. In this review, we will focus on recent advances in...

    Weng Chuan Peng, Lianne J. Kraaier, Thomas A. Kluiver in Experimental & Molecular Medicine
    Article Open access 18 October 2021
  9. Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters

    The vitamin D receptor (VDR), in addition to other nuclear receptors, the pregnane X receptor (PXR) and constitutive androstane receptor (CAR), is...

    Keumhan Noh, Edwin C. Y. Chow, ... K. Sandy Pang in The AAPS Journal
    Article 01 June 2022
  10. Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids

    The pregnane X receptor (PXR) is a ligand-activated nuclear receptor controlling hepatocyte expression of numerous genes. Although expression changes...

    Tomas Smutny, Veronika Bernhauerova, ... Petr Pavek in Archives of Toxicology
    Article 23 October 2021
  11. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells

    Targeted gene therapy has become a promising approach for lung cancer treatment. In our previous work, we reported that the targeted expression of...

    Shipeng Chen, Lian Guan, ... Lin Xu in Journal of Zhejiang University-SCIENCE B
    Article 21 November 2022
  12. Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities

    As progressive, chronic, incurable and common reasons for disability and death, neurodegenerative diseases (NDDs) are significant threats to human...

    Mohammad Mehdi Gravandi, Sajad Fakhri, ... Haroon Khan in Metabolic Brain Disease
    Article 14 May 2021
  13. Role of Extracellular Vesicles in Cancer Pathogenesis

    Extracellular vesicles (EVs) are cell-derived membranous vesicles necessary for intercellular communication. According to the size, biogenesis,...
    Mohamed Ibrahim Elewaily in Handbook of Cancer and Immunology
    Living reference work entry 2023
  14. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding

    Background

    Circulating high-mobility group box 1 (HMGB1) plays important roles in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)....

    Minjie Lin, Jungke Long, ... Melanie J. Scott in Molecular Medicine
    Article Open access 25 November 2020
  15. ATF3 in atherosclerosis: a controversial transcription factor

    Abstract

    Atherosclerosis, the pathophysiological basis of most malignant cardiovascular diseases, remains a global concern. Transcription factors play...

    Bingyu Wang, ** Yang, ... Jianqing Zhou in Journal of Molecular Medicine
    Article 08 October 2022
  16. Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter

    Background

    Ovarian cancer (OC) is distinguished by its aggressive nature and the limited efficacy of current treatment strategies. Recent studies have...

    Songwei Feng, Bo Ding, ... Yang Shen in Journal of Translational Medicine
    Article Open access 15 March 2024
  17. Genomic Insights into Non-steroidal Nuclear Receptors in Prostate and Breast Cancer

    Alterations in transcriptional programs are a fundamental feature of prostate (PCa) and breast cancerBreast cancers (BrCa), and frequently target the...
    Sajad A. Wani, Moray J. Campbell in Nuclear Receptors in Human Health and Disease
    Chapter 2022
  18. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics

    Recent advances have brought forth the complex interplay between tumor cell plasticity and its consequential impact on drug resistance and tumor...

    Bandari BharathwajChetty, Anjana Sajeev, ... Ajaikumar B. Kunnumakkara in Cancer and Metastasis Reviews
    Article 22 March 2024
  19. Natural compounds targeting nuclear receptors for effective cancer therapy

    Human nuclear receptors (NRs) are a family of forty-eight transcription factors that modulate gene expression both spatially and temporally. Numerous...

    Mangala Hegde, Sosmitha Girisa, ... Ajaikumar B. Kunnumakkara in Cancer and Metastasis Reviews
    Article 08 December 2022
  20. Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review

    Tumor cells employ multiple signaling mediators to escape the hypoxic condition and trigger angiogenesis and metastasis. As a critical orchestrate of...

    Sajad Fakhri, Seyed Zachariah Moradi, ... Anupam Bishayee in Cancer and Metastasis Reviews
    Article 04 October 2023
Did you find what you were looking for? Share feedback.